Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in phakic patients

被引：0
|
作者：
Christina Rennie
Andrew Lotery
Jo Payne
Moushmi Singh
Faruque Ghanchi
机构：
[1] University Hospital Southampton NHS Foundation Trust,
[2] Faculty of Medicine,undefined
[3] University of Southampton,undefined
[4] AbbVie Ltd,undefined
[5] AbbVie House,undefined
[6] Vanwall Business Park,undefined
[7] Bradford Teaching Hospitals NHS Foundation Trust,undefined
来源：
Eye | 2024年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：215 / 223
页数：8
相关论文
共 50 条
  • [41] The impact of ganglion cell layer cysts in diabetic macular oedema treated with anti-vascular endothelial growth factor
    Ceklic, Lala
    Huf, Wolfgang
    Ebneter, Andreas
    Wolf, Sebastian
    Zinkernagel, Martin S.
    Munk, Marion R.
    ACTA OPHTHALMOLOGICA, 2019, 97 (08) : E1041 - E1047
  • [42] Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema
    Durrani, Asad Farooq
    Momenaei, Bita
    Wakabayashi, Taku
    Vemula, Sudheshna
    Pandit, Saagar A.
    Hsu, Jason
    Ho, Allen C.
    Spirn, Marc J.
    Klufas, Michael A.
    Garg, Sunir J.
    Vander, James F.
    Regillo, Carl D.
    Chiang, Allen
    Kuriyan, Ajay E.
    Yonekawa, Yoshihiro
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2024, 108 (09) : 1257 - 1262
  • [43] Gender-related differences in patients treated with intravitreal anti-vascular endothelial growth factor medication for diabetic macular oedema
    Schiefelbein, Johannes
    Mueller, Michael
    Kern, Christoph
    Herold, Tina
    Liegl, Raffael
    Fasler, Katrin
    Jeliazkova, Diana
    Priglinger, Siegfried
    Kortuem, Karsten Ulrich
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (06) : 1410 - 1417
  • [44] Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization
    Wontae Yoon
    Jihyun Yoon
    Seung Kwan Na
    Jihyun Lee
    Jaemin Kim
    Jong Woo Kim
    Han Joo Cho
    Scientific Reports, 11
  • [45] Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization
    Yoon, Wontae
    Yoon, Jihyun
    Na, Seung Kwan
    Lee, Jihyun
    Kim, Jaemin
    Kim, Jong Woo
    Cho, Han Joo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting
    Gandhi, Jagdeep Singh
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 199 : 255 - 256
  • [47] TREATMENT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-RESISTANT DIABETIC MACULAR EDEMA WITH DEXAMETHASONE INTRAVITREAL IMPLANT
    Lazic, Ratimir
    Lukic, Marko
    Boras, Ivan
    Draca, Natasa
    Vlasic, Marko
    Gabric, Nikica
    Tomic, Zoran
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (04): : 719 - 724
  • [48] Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting
    Maggio, Emilia
    Sartore, Mauro
    Attanasio, Marcella
    Maraone, Giorgia
    Guerriero, Massimo
    Polito, Antonio
    Pertile, Grazia
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2018, 195 : 209 - 222
  • [49] The effect of intravitreal dexamethasone implantation on diabetic macular edema refractory to anti-vascular endothelial growth factor treatment
    Kim, Kiyoung
    Kim, Eung Suk
    Kim, Do Gyun
    Yu, Seung-Young
    EXPERT REVIEW OF OPHTHALMOLOGY, 2022, 17 (04) : 281 - 287
  • [50] Foveal thickness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema
    Gabriel Willmann
    Antonio Brunno Nepomuceno
    Katharina Messias
    Leticia Barroso
    Ingrid U.Scott
    André Messias
    Rodrigo Jorge
    International Journal of Ophthalmology, 2017, (05) : 760 - 764
12345